Stoeckel K, McNamara P J, Hoppe-Seyler G, Blumberg A, Keller E
Clin Pharmacol Ther. 1983 May;33(5):633-41. doi: 10.1038/clpt.1983.86.
The disposition profile of ceftriaxone was studied in 12 functionally anephric patients (creatinine clearance less than 10 ml/min) who received bolus injections of 150, 500, and 1500 mg IV in a noncrossover fashion. As in healthy subjects, the kinetics in uremic patients were nonlinear for total (bound plus unbound) and linear for free (unbound) drug. The plasma protein binding was reduced due to a decreased association constant, resulting in a doubling of the free fraction in plasma. Ten of 12 patients showed nonrenal clearance values of unbound drug (ClFNR) identical to those in healthy adults and only minor increases in their biologic t1/2(beta) compared to normal (12 and 8 hr). These patients would require no dose adjustments in their dosing regimen. Two of the patients exhibited decreased ClFNR values and increased t1/2(alpha) of 20 and 34 hr. Anephric patients with impaired nonrenal elimination would require minor dose adjustments.
在12名功能性无肾患者(肌酐清除率低于10 ml/分钟)中研究了头孢曲松的处置情况,这些患者以非交叉方式静脉推注150、500和1500 mg药物。与健康受试者一样,尿毒症患者中总药物(结合加未结合)的动力学呈非线性,而游离(未结合)药物的动力学呈线性。由于结合常数降低,血浆蛋白结合减少,导致血浆中游离分数加倍。12名患者中有10名的游离药物非肾清除率(ClFNR)值与健康成年人相同,与正常情况相比,其生物半衰期(β)仅略有增加(12小时和8小时)。这些患者在给药方案中无需调整剂量。其中两名患者的ClFNR值降低,半衰期(α)分别增加至20小时和34小时。非肾清除功能受损 的无肾患者需要进行小剂量调整。